Literature DB >> 17661121

Prevalence and clinical significance of antibodies to citrullinated fibrinogen (ACF) in Chinese patients with rheumatoid arthritis.

Yi Zhao1, Xin Tian, Zhanguo Li.   

Abstract

It has been reported that citrullinated fibrin(ogen) deposits in the inflamed joints played an important role in the pathogenesis of rheumatoid arthritis (RA). Although antibodies to citrullinated fibrinogen (ACF) have been detected in the sera of RA patients, the associations between ACF and RA remain unclear. In this study, human fibrinogen was citrullinated by peptidylarginine deiminase in vitro, and the ACF were detected by an enzyme-linked immunosorbent assay in rheumatic patients, including 183 RA, 121 systemic lupus erythematosus, 48 osteoarthritis, and 108 healthy controls. The prevalence of ACF was determined, and the associations between ACF and RA were evaluated. It was shown that the sensitivity and specificity of ACF in RA were 67.21 and 84.84%, respectively. There were significant correlations between ACF and erythrocyte sedimentation rate, anti-cyclic citrullinated peptide antibody, and anti-keratin antibodies (AKA). In radiographic progression, the RA patients with ACF had higher scores than those without ACF according to the Sharp-van der Heijde method. In addition, ACF was often positive in the RA patients who were IgM rheumatoid factor negative or AKA negative or anti-perinuclear factor negative. The results indicate that ACF assay is helpful for the diagnosis of RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661121     DOI: 10.1007/s10067-007-0544-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

2.  Diagnostic value of antibodies to filaggrin in rheumatoid arthritis.

Authors:  S L Slack; M Mannik; B A Dale
Journal:  J Rheumatol       Date:  1998-05       Impact factor: 4.666

3.  Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Miyako Ohtake-Yamanaka; Yuko Okazaki; Tetsuji Sawada; Kazuhiko Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

4.  Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.

Authors:  N Bizzaro; G Mazzanti; E Tonutti; D Villalta; R Tozzoli
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

5.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.

Authors:  M M J Nielen; A R van der Horst; D van Schaardenburg; I E van der Horst-Bruinsma; R J van de Stadt; L Aarden; B A C Dijkmans; D Hamann
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

7.  Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis.

Authors:  Suk Woo Choi; Mi Kyoung Lim; Dong Hyuk Shin; Jeong Jin Park; Seung Cheol Shim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

8.  Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.

Authors:  Xiaofeng Zeng; Maixing Ai; Xinping Tian; Xiaodan Gan; Yanping Shi; Qinfang Song; Fulin Tang
Journal:  J Rheumatol       Date:  2003-07       Impact factor: 4.666

9.  Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors.

Authors:  S Bas; T V Perneger; M Seitz; J-M Tiercy; P Roux-Lombard; P A Guerne
Journal:  Rheumatology (Oxford)       Date:  2002-07       Impact factor: 7.580

10.  High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.

Authors:  K Suzuki; T Sawada; A Murakami; T Matsui; S Tohma; K Nakazono; M Takemura; Y Takasaki; T Mimori; K Yamamoto
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

View more
  5 in total

Review 1.  A new look at rheumatology in China--opportunities and challenges.

Authors:  Zhan-Guo Li
Journal:  Nat Rev Rheumatol       Date:  2015-01-20       Impact factor: 20.543

2.  A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis.

Authors:  Kristen N Cordova; Van C Willis; Kathryn Haskins; V Michael Holers
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

3.  Application of contrast-enhanced ultrasonography and ultrasonography scores in rheumatoid arthritis.

Authors:  Xiao-Han Cai; Shu-Ping Yang; Hao-Lin Shen; Li-Qing Lin; Rong Zhong; Rui-Ming Wu; Guo-Rong Lv
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 4.  Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.

Authors:  Qinghua Fang; Jiaxin Ou; Kutty Selva Nandakumar
Journal:  Mediators Inflamm       Date:  2019-10-27       Impact factor: 4.711

5.  Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.

Authors:  Raimon Sanmartí; Eduard Graell; Maria L Perez; Guadalupe Ercilla; Odette Viñas; Jose A Gómez-Puerta; Jordi Gratacós; Alejandro Balsa; Maria J Gómara; Marta Larrosa; Juan D Cañete; Isabel Haro
Journal:  Arthritis Res Ther       Date:  2009-09-02       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.